Navigation Links
Uroplasty to Present at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Device Conference
Date:11/30/2011

MINNEAPOLIS, Nov. 30, 2011 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, announced today that David Kaysen, President and CEO, and Medi Jiwani, Vice President and CFO, will present the Company's business strategy and financial results at the Canaccord Genuity 6th Annual Cardiovascular, Aesthetics & Metabolic Disorders Medical Device Conference at 4:00 PM PT on Tuesday, December 6, 2011 at The St. Regis Hotel in San Francisco.

Attendance at the conference is by invitation only.  A live audio webcast of the presentation will be broadcast via the Internet.  Those interested in listening to the webcast may access it at http://www.newswire.ca/en/webcast/viewEvent.cgi?eventID=3742860, or through Uroplasty's website at www.uroplasty.com. An archived replay of the presentation will be available for 90 days.

About Uroplasty, Inc.

Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned subsidiaries in The Netherlands and the United Kingdom, is a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions. Our focus is the continued commercialization of our Urgent® PC Neuromodulation System, the only FDA-cleared neuromodulation system that delivers posterior tibial nerve stimulation (PTNS) for the office-based treatment of overactive bladder and associated symptoms of urgency, frequency and urge incontinence. We also offer Macroplastique® Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. For more information on the company and its products, please visit Uroplasty, Inc. at www.uroplasty.com.

For Further Information:

Uroplasty, Inc.

David Kaysen, President and CEO, or

Medi Jiwani, Vice President, CFO, Treasurer

952.426.6140

 

EVC Group

Doug Sherk/Jenifer Kirtland (Investors), 415.568.9349

Chris Gale (Media), 646.201.5431

   

 


'/>"/>
SOURCE Uroplasty, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator
2. Uroplasty Reports Fiscal Second Quarter 2012 Financial Results
3. Uroplasty to Issue Second Quarter 2012 Financial Results on October 27, 2011
4. Uroplasty to Present at the 6th Annual JMP Securities Healthcare Conference
5. Uroplasty Reports Financial Results for the First Quarter of Fiscal 2012
6. Uroplasty to Issue First Quarter 2012 Financial Results on July 28, 2011
7. Two Additional Private Payers Provide Coverage for Posterior Tibial Nerve Stimulation Delivered Using the Uroplasty Urgent® PC Neuromodulation System
8. Uroplasty on Preliminary List of Additions to Russell 3000® and Russell Global® Indexes
9. Uroplastys Dave Kaysen to Ring NASDAQ Closing Bell
10. Uroplasty Reports Financial Results for the Fiscal Fourth Quarter and Full Year 2011
11. Uroplasty to Present at the JMP Securities Research Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... , July 24, 2017  Diplomat Pharmacy, Inc. ... will release its second quarter 2017 operating results on ... conference call to follow at 5:00 p.m. ET. ... may listen to a live broadcast of the conference ... and referencing participant code 51641230 approximately 15 minutes prior ...
(Date:7/20/2017)... July 20, 2017  Prime Therapeutics LLC (Prime) released this ... M.D., following today,s Institute for Clinical and Economic Review,s (ICER) ... the effectiveness and value of abuse-deterrent formulations (ADF) of opioids. ... roundtable at the meeting. ... cost benefit to the use of abuse-deterrent formulations (ADF) in ...
(Date:7/14/2017)... 2017 It should come as no surprise to ... in the midst of a crippling opioid epidemic. According to ... number of overdose deaths from opiate-based medications has quadrupled, Says, ... million dead from 2001 to 2015". During this time, the ... similarly quadrupled, drawing a compelling link between prescription and eventual ...
Breaking Medicine Technology:
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... sleep management solution focused on delivering end-to-end sleep health care at ... , Recent literature shows that adherence rates for positive airway pressure (PAP) therapy, ...
(Date:7/24/2017)... ... July 24, 2017 , ... The ... StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in collaboration with website ... Awards to be consumer voted. The Magic Wand Rechargeable won in stiff competition ...
(Date:7/24/2017)... ... July 24, 2017 , ... Clinical Quality ... Consulting **, Aug. 22-23, 2017 – Arlington, VA, http://www.fdanews.com/cqa , Early ... FDA scrutiny and growing demands to track and report adverse events place even ...
(Date:7/24/2017)... Island (PRWEB) , ... July 24, 2017 , ... ... a new office at 2307 Bellmore Avenue, Bellmore, New York, (516) 784-5858. The ... Jordan Fabrikant, M.D. and physician assistants Lori Friedman and Fruma Leah Wiederman. ...
(Date:7/24/2017)... ... ... “A Short Walk to the Mailbox”: a remarkable memoir of an unconventional ... Ed Clark. Ed Clark is a church music director and choral conductor. ... music and worship leader for over fifty years. He has a master’s degree ...
Breaking Medicine News(10 mins):